Faculty Information - Kenji Wada

Present specialized field

Journal

Presentation

Belonging society

（Last updated : 2024-04-12 11:53:23）

Kenji Wada
Department Kawasaki Medical School Kawasaki Medical School, Department of Dementia Medicine,

Position Professor

■ Present specialized field

Neuroscience-general, Cognitive and brain science, Neurology, General internal medicine

■ Journal

1.	2023/01/26	Differences in Parkinson's disease treatment between neurology and other departments in Japan
2.	2023/01/02	Non-ergot dopamine agonist therapy for Parkinson's disease in Japan: A claims database analysis
3.	2022/10/14	An exploratory, open-label, randomized, multicenter trial of hachimijiogan for mild Alzheimer’s disease
4.	2021/03/23	Economic Burden of Alzheimer’s Disease Dementia in Japan
5.	2021	A case of pneumonia with asymptomatic reversible splenial lesion
6.	2020/10/10	Personality traits associated with freezing of gait in Parkinson's disease patients
7.	2020/02	A program of exercise, brain training, and lecture toprevent cognitive decline
8.	2020/02	A Single-institution Study on Predictors of Short-term Progression from MildCognitive Impairment in Parkinson’s Disease to Parkinson’s Disease with Dementia
9.	2020/02	Predictors for Incident Mild Parkinsonian Signs in Older Japanese
10.	2020/01/07	ABC Dementia Scale Classifies Alzheimer’s　Disease Patients into Subgroups characterized by Activities of Daily Living,Behavioral and Psychological Symptoms of Dementia,and Cognitive Function.
11.	2019/09/10	Global Clinical Dementia Rating Score of 0.5 May Not Be an Accurate Criterion to Identify Individuals with Mild Cognitive Impairment
12.	2019/01	Development of a novel convenient Alzheimer's disease assessment scale, the ABC Dementia Scale, using item response theory.
13.	2018/01	ABC Dementia Scale Study Group.　ABC Dementia Scale: A Quick Assessment Tool for Determining Alzheimer's Disease Severity
14.	2017/06	Association between exercise habits and subcortical graymatter volumes　in healthy elderly people: A population-based study in Japan.
15.	2017/06	Clinical diversity caused by novel IGHMBP2 variants.
16.	2016/12	Prevalence of progressive supranuclear palsy in Yonago: change throughout a decade
17.	2016	Clinical assessment and prevalence of parkinsonism in Japanese elderly people.
18.	2016	Longitudinal course of mild parkinsonian signs in elderly people: A population-based study in Japan.
19.	2015/03	Association of cerebral white matter lesions with cognitive function and mood in Japanese elderly people: a population-based study.
20.	2015/03	Diagnostic Accuracy of 123I-Meta-Iodobenzylguanidine Myocardial Scintigraphy in Dementia with Lewy Bodies: A Multicenter Study.
21.	2014	Clinical evaluation of fatigue in Japanese patients with Parkinson's disease.
22.	2013	Autopsy-confirmed progressive supranuclear palsy with decreased uptake of metaiodobenzylguanidine.
23.	2013	Depression and cognitive impairment in patients with mild parkinsonian signs.
24.	2013	Impulsive compulsive behaviors in Japanese Parkinson's disease patients and utility of the Japanese version of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's disease.
25.	2012/12	Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
26.	2012/06	Multicentre population-based dementia prevalence survey in Japan: a preliminary report.
27.	2012/02	Prevalence of Dementia and Mild Cognitive Impairment in the Rural Island Town of Ama-cho, Japan.
28.	2012	Epidemiological survey of frontotemporal lobar degeneration in tottori prefecture, Japan.
29.	2011/05	Mild parkinsonian signs in a community-dwelling elderly population sample in Japan.
30.	2011/05	Open label trial to evaluate the efficacy and safety of Yokukansan, a traditional Asian medicine, in dementia with Lewy bodies.
31.	2009/05	Assessment of dementia in patients with multiple system atrophy
32.	2008/10	Epidemiological study of acute encephalitis in Tottori Prefecture, Japan.
33.	2008	Assessment of hallucinations in Parkinson's disease using a novel scale.
34.	2008	Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson's disease.
35.	2008	Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
36.	2008	Serum heart-fatty acid binding protein levels in patients with Lewy body disease.
37.	2008	Sugar Chains of Cerebrospinal Fluid Transferrin as a New Biological Marker of Alzheimer's Disease.
38.	2008	The effect of donepezil on increased regional cerebral blood flow in the posterior cingulate cortex of a patient with Parkinson's disease dementia.
39.	2007	Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination.
40.	2007	Diagnostic markers for diagnosing dementia with Lewy bodies: CSF and MIBG cardiac scintigraphy study
41.	2007	Longitudinal changes in the prevalence of dementia in a Japanese rural area.
42.	2007	Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.
43.	2006	Neurobiological studies of dementia--biological markers and neuroprotective strategies for Alzheimer disease
44.	2004	A haplotype of the methylenetetrahydrofolate reductase gene is protective against late-onset Alzheimer's disease
45.	2004	A novel presenilin 1 mutation (Y154N) in a patient with early onset Alzheimer's disease with spastic paraparesis.
46.	2004	Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients
47.	2004	Genetic analysis of familial Alzheimer’s disease in a Japanese population. In Molecular Neurobiology of Alzheimer Disease and Related Disorders
48.	2004	Novel amyloid precursor protein gene missense mutation (D678N) in probable familial Alzheimer's disease
49.	2004	The regulatory region polymorphisms of the MTHFR gene are not associated with Alzheimer's disease
50.	2003	Axonal and demyelinating forms of the MPZ Thr124Met mutation
51.	2003	PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells
52.	2003	Production of dopaminergic neurons for cell therapy in the treatment of Parkinson's disease
53.	2002	An epidemiological genetic study of Charcot-Marie-Tooth disease in western Japan
54.	2001	Apolipoprotein E promoter-186 T/G polymorphism and Japanese Alzheimer’s disease
55.	2001	Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive suprauclear palsy
56.	2001	Identiffication of abberant tau mRNA in brain tissue
57.	2000	Estrogen receptor gene polymorphisms in patients with Alzheimer’s disease, vascular dementia and Alcohol-associated dementia
58.	2000	Lipoprotein(a) phenotypes in patients with vascular dementia
59.	2000	The expression of Presenilin 1 mRNA in skin fibroblasts and Brains from sporadic Alzheimer’s disease
60.	1999	A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy
61.	1999	Alteration in brain presenilin-1 mRNA in sporadic Alzheimer's disease
62.	1999	No association between presenilin-2 polymorphism and Alzheimer's disase in a Japanese population
63.	1999	Positive Association between an estrogen receptor gene polymorphism and Parkinson’s disease with dementia
64.	1999	Screening for mutations of tau gene in patients with tauopathy
65.	1998	Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease
66.	1998	Epidemiologic and genetic studies of dementia of the Alzheimer type in Japan
67.	1998	High concentrations of PS-1 mRNA in skin fibroblasts of patients with Down's syndrome
68.	1998	Intracranial calcification with IgG lambda M-proteinaemia: a case report.
69.	1998	Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan.
70.	1998	The expression of presenilin-1 mRNA in skin fibroblasts from Alzheimer's disease
71.	1997	Genetic Association of Estrogen receptor gene polymorphisms with Alzheimer’s disease
72.	1997	Screening for mutation of the presenilin 2 gene in Alzheimer's disease
73.	1996	Analysis of amyloid precursor protein mRNAs in skin fibroblasts in Down's syndrome
74.	1996	Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia
75.	1996	Presenilin-1 polymorphism in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia in Japanese population
76.	1996	Tau proteins in cerebrospinal fluid from patients with Alzheimer's disease: a longitudinal study
77.	1994	Point mutation in platelet mitochondrial tRNA(Leu(UUR)) in patient with cluster headache.
Display 5 items
Display all(77)

■ Presentation

1.	2019/11	ECONOMIC BURDEN OF ALZHEIMER’S DISEASE DEMENTIA IN JAPAN （Poster notice，General）
2.	2017/06	Longitudinal study of freezing of gait in patients with Parkinson’s disease （Poster notice，General）
3.	2017/06	Predictor of progressive mild cognitive impairment in patients with Parkinson's disease. （Poster notice，General）
4.	2015/12	The association with cognitive function in Lewy body disease: The study of serum biomarkers. （Poster notice，General）
5.	2015/06	A study on subjective and objective freezing phenomena in Parkinson’s disease. （Poster notice，General）
6.	2015/06	Association between dementia and probable REM sleep behavior disorder (RBD) using the Japanese version of the RBD screening questionnaire in patients with Parkinson's disease （Poster notice，General）
7.	2015/06	Longitudinal course of mild parkinsonian signs in elderly people: A population-based study in Japan （Poster notice，General）
8.	2014/06	Comparison of MoCA and MMSE for evaluating cognitive function in Japanese patients with Parkinson's disease （Poster notice，General）
9.	2013/10	Cerebrospinal fluid biomarkers in clinical diagnosis of Lewy body spectrum disorder （Poster notice，General）
10.	2013/07	Thymosin β4 and Retinol binding protein 4 as potential serum biomarkers for diagnosis of dementia with Lewy bodies. （Poster notice，General）
11.	2013/06	Clinical evaluation of fatigue in Japanese patients with Parkinson’s disease （Poster notice，General）
12.	2012/11	Clinical assessment of subjects with idiopathic normal pressure hydrocephalus features on MRI in a community-dwelling elderly population sample in Japan （Poster notice，General）
13.	2011/09	Parkinsonism in a community-dwelling elderly population sample in Japan （Poster notice，General）
14.	2011/09	Prevalence of dementia and mild cognitive impairment in the rural island town of Ama-cho, Japan. （Poster notice，General）
15.	2010/12	Depression and cognitive impairment in a patient with mild parkinsoniansigns among community-dwelling elderly population sample in Japan （Poster notice，General）
16.	2002/10	Tau study in Alzheimer’s disease （Poster notice，General）
17.	2002/06	Phosphorylation of tau protein and neuronal cell death induced by peptidyltransferase inhibitors （Poster notice，General）
18.	2002/06	Phosphorylation of tau protein in cultured cells induced by polyinosinic-polycytidylic acid （Poster notice，General）
19.	2002/04	Genetic analysis of vascular factors in Alzheimer's disease. （Poster notice，General）
20.	2001/03	Identification of aberrant splicing variant of Tau mRNA (E10-/E11-) from brain tissue （Poster notice，General）
Display 5 items
Display all(20)

■ Belonging society

1.		Japan Society of Dementia Research
2.		The Japanese Society of Internal Medicine
3.		Japanese Society of Neurology
4.		The Japan Geriatrics Society
5.		Movement Disorder Society of Japan
6.		The Japan Stroke Society
7.		Japanese Society for Neuroinfectious Diseases
8.		Japan Psychogeriatric Society
Display 5 items
Display all(8)